Norway's wealth fund pushes for more women on emerging market company boards
Essa Pharma Inc Reports Results For The Quarter Ended In December: Earnings Summary
Essa Pharma Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview
Brief: Essa Pharma Presents Updated Phase 1 Masofaniten Epi-7386 Clinical Data At The 2024 Asco Genitourinary Cancers Symposium
Essa Pharma Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: Essa Pharma Provides Corporate Update And Reports Financial Results For Q4 And Year Ended September 30 2023
Essa Pharma Inc Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
Brief: Essa Pharma Enters Into At-The-Market Equity Offering Sales Agreement
Brief: Essa Pharma Presents Updated Phase 1 Masofaniten (Epi-7386) Clinical Data At The 30Th Annual Prostate Cancer Foundation Scientific Retreat
Brief: Essa Pharma Presents Updated Phase 1 Masofaniten (Epi-7386) Clinical Data
Brief: Essa Pharma Announces Initiation Of Phase 2 Study Evaluating Masofaniten In Combination With Enzalutamide In Patients With A Type Of Prostate Cancer
Brief: ESSA Pharma Inc - Each Of President And CEO, Executive Vice President And Chief Operating Officer Established Automatic Securities Disposition Plans
Essa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary
Essa Pharma Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview
Brief: ESSA Pharma Appoints Lauren Merendino To Its Board Of Directors
Essa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: Essa Pharma Provides Corporate Update And Reports Financial Results For Fiscal Q2 Ended March 31, 2023
Essa Pharma Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-SiriusPoint, Nutex Health, Barrick Gold